Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
---|
05/16/2013 | US20130122076 Transdermal Patch Having Ultrasound Transducer for Administering Thrombolytic Reagents to Patients Having a Protein Misfolding Disease |
05/16/2013 | US20130122075 Encapsulated transfer factor compositions and methods of use |
05/16/2013 | US20130122069 Nanofiber laminate sheet |
05/16/2013 | US20130122065 Pharmaceutical Composition |
05/16/2013 | US20130122064 Ophthalmic Depot Formulations for Periocular or Suconjunctival Administration |
05/16/2013 | US20130122063 Nanotubes as Mitochondrial Uncouplers |
05/16/2013 | US20130122061 Delayed Release Tablet With Defined Core Geometry |
05/16/2013 | US20130122060 Using bucky paper as a therapeutic aid in medical applications |
05/16/2013 | US20130122058 Engineering of polymer-stabilized nanoparticles for drugs with log p values below 6 by controlled antisolvent precipitation |
05/16/2013 | US20130122056 Ratiometric Combinatorial Drug Delivery |
05/16/2013 | US20130122053 Synthetic triterpenoids and tricyclic-bis-enones for use in stimulating bone and cartilage growth |
05/16/2013 | US20130122051 Methods of preparing progesterone pharmaceutical compositions |
05/16/2013 | US20130121931 Method for controlling continuousness of deodorant effect after consumption of chewing gum composition and a chewing gum composition |
05/16/2013 | US20130121929 Polyol and Polyether Iron Oxide Complexes as Pharmacological and/or MRI Contrast Agents |
05/16/2013 | US20130121918 Nano-Hybrid Delivery System for Sequential Utilization of Passive and Active Targeting |
05/16/2013 | US20130119090 Foamable sanitizing compositions |
05/16/2013 | US20130118491 Delivery of Active Agents |
05/16/2013 | CA2857953A1 An extended release formulation of a direct thrombin inhibitor |
05/16/2013 | CA2855373A1 Malignant tumor treatment agent and food and drink including same |
05/16/2013 | CA2855180A1 Trolox derivative-modified fat-soluble anti-cancer pharmaceutical compounds, preparations, preparing methods and use thereof |
05/16/2013 | CA2854984A1 Lubricious coatings |
05/16/2013 | CA2853894A1 Film packaging for oral biologics |
05/16/2013 | CA2851069A1 New coated controlled release active agent carriers |
05/15/2013 | EP2592146A2 Methods and compositions for treating prostate cancer |
05/15/2013 | EP2592080A1 Crystal of fused pyridine compound salt |
05/15/2013 | EP2591806A1 Medicinal composition |
05/15/2013 | EP2591802A1 Vaccine compositions based on sticholysin encapsulated in liposomes |
05/15/2013 | EP2591801A1 Nanoparticle compositions for generation of regulatory T cells and treatment of autoimmune diseases and other chronic inflammatory conditions |
05/15/2013 | EP2591792A1 Composition for nucleic acid delivery, carrier composition, pharmaceutical composition using the composition for nucleic acid delivery or the carrier composition, and method for delivering nucleic acid |
05/15/2013 | EP2591791A1 Bulbine frutescens plant sap |
05/15/2013 | EP2591781A1 Particle coating preparation |
05/15/2013 | EP2591780A1 Topical formulations with a tertiary amine oxide |
05/15/2013 | EP2591779A1 Topical formulations with a tertiary amine oxide |
05/15/2013 | EP2591774A1 Orally disintegrating tablet |
05/15/2013 | EP2591773A2 Time-delayed sustained release pharmaceutical composition comprising dapoxetine for oral administration |
05/15/2013 | EP2591772A1 New coated controlled release active agent carriers |
05/15/2013 | EP2591771A1 Preservation of bioactive materials by freeze dried foam |
05/15/2013 | EP2591770A2 Compositions for siRNA delivery and methods of manufacturing and using same |
05/15/2013 | EP2591769A2 Compounds, compositions, kits and methods of use to topically treat acne and other skin conditions by administering a 19-nor containing vitamin D analog. |
05/15/2013 | EP2591768A1 Single unit dosage formulations of sevelamer and fat soluble vitamins and surface active agents |
05/15/2013 | EP2591117A1 Delivery of self-replicating rna using biodegradable polymer particles |
05/15/2013 | EP2590714A1 Dry compositions and devices containing such dry compositions for use in photodynamic therapy or photodynamic diagnosis |
05/15/2013 | EP2590674A2 Compositions and methods for treating influenza |
05/15/2013 | EP2590666A1 Topical application of erythropoietin for the treatment of eye disorders and injuries |
05/15/2013 | EP2590661A1 Improved method for stem cell differentiation in vivo by delivery of morphogenes with mesoporous silica and corresponding pharmaceutical active ingredients. |
05/15/2013 | EP2590652A1 Pharmaceutical compositions containing vanoxerine |
05/15/2013 | EP2590650A2 Pharmaceutical compositions including carbamoyloxy arylalkanoyl arylpiperazine compound |
05/15/2013 | EP2590638A1 Trans-epithelial osmotic collyrium for the treatment of keratoconus |
05/15/2013 | EP2590636A1 Novel gastro- retentive dosage forms comprising a gaba analog and an opioid |
05/15/2013 | EP2590635A1 Chewing gum containing a cross-linked gelatin matrix gum base |
05/15/2013 | EP2590634A2 Combination immediate/delayed release delivery system for short half-life pharmaceuticals including remogliflozin |
05/15/2013 | EP2590633A1 Dosage form |
05/15/2013 | EP2590632A1 Pharmaceutical form for combating chemical submission of a medicament |
05/15/2013 | EP2590631A2 Formulation for co-therapy treatment of diabetes |
05/15/2013 | EP2590630A1 Oral dosage form of deferasirox |
05/15/2013 | EP2590629A2 Biodegradable phase separated segmented multi block co-polymers and release of biologically active polypeptides |
05/15/2013 | EP2590628A1 Implant processing methods for thermally labile and other bioactive agents and implants prepared from same |
05/15/2013 | EP2590627A1 Aliskiren in form of a solid dispersion |
05/15/2013 | EP2590626A1 Liposomes with lipids having an advantageous pka- value for rna delivery |
05/15/2013 | EP2590625A2 Cationic oil-in-water emulsions |
05/15/2013 | EP2590620A1 Stable aqueous formulations comprising poorly water soluble active ingredients |
05/15/2013 | EP2590615A2 Multi-layer tablet formation by adhering tablet bodies together |
05/15/2013 | EP2590614A1 Method for dosing a fluid formulation containing a medicinal substance |
05/15/2013 | CN202933245U Traditional Chinese medicine paster for bellyache |
05/15/2013 | CN202933244U Vomit preventing and stopping acupoint patch |
05/15/2013 | CN202933243U Patch |
05/15/2013 | CN1972717B Binary thermo-gelling composition |
05/15/2013 | CN103108658A Antibody formulations |
05/15/2013 | CN103108637A Methods of intravenous administration of glyburide and other drugs |
05/15/2013 | CN103108635A Liquid formulations of rupatadine fumarate |
05/15/2013 | CN103108629A Mesalazine tablet having improved dissolution |
05/15/2013 | CN103108628A Formulations for infusion of type B lantibiotics |
05/15/2013 | CN103108627A Pharmaceutical depot for 5-fluoro-2 [ [ (1s) -1- (5-fluoro-2-pyridyl)ethyl]amino]-6-[(5-isopropoxy-1h-pyrazol-3-yl)amino]pyridine-3-carbonitrile |
05/15/2013 | CN103108626A Tetranectin-apolipoprotein A-I, lipid particles containing it and its use |
05/15/2013 | CN103108625A Parenteral formulations of elacytarabine derivatives |
05/15/2013 | CN103108624A Non-aqueous oily injectable formulation exhibiting preservative efficacy |
05/15/2013 | CN103108623A Composition for the treatment of superficial lesions |
05/15/2013 | CN103103148A Method for screening Bacillus subtilis applicable to taking corn starch sewage as carbon source of culture medium and production method of wettable powder |
05/15/2013 | CN103102479A Reduction sensitive fluorescent nano micelle with FRET (Fluorescence Resonance Energy Transfer) effect and preparation method thereof |
05/15/2013 | CN103102271A Industrialized preparation method of guacetisal and medical application of dry suspension |
05/15/2013 | CN103100091A Compound seaweed gum and application thereof to capsule preparation |
05/15/2013 | CN103100090A Hard capsule shell material and production process thereof |
05/15/2013 | CN103100089A Oral pH responsive intestinal targeting vector as well as preparation method and applications thereof |
05/15/2013 | CN103100088A Macromolecule skin penetration enhancer as well as preparation method and applications thereof |
05/15/2013 | CN103100071A Pill used for treating kidney deficiency and diuresis |
05/15/2013 | CN103100069A Adenophora stricta tablets for clearing heat and eliminating phlegm |
05/15/2013 | CN103100068A Traditional Chinese medicine powder externally applied to acupoints for treating pneumonia |
05/15/2013 | CN103100067A Rattan stilbene capsules for resolving hard lump |
05/15/2013 | CN103100063A Traditional Chinese medicine for treating damp-heat type gallstone |
05/15/2013 | CN103100054A Preparation method of traditional Chinese medicine lotion for treating acute mastitis caused by pain |
05/15/2013 | CN103100050A Chinese medicament for treating angina |
05/15/2013 | CN103100049A Traditional Chinese medicine preparation for treating gall-stone and cholecystitis, and preparation method thereof |
05/15/2013 | CN103100044A Traditional Chinese medicine pill for treating cervical tuberculous lymphadenitis |
05/15/2013 | CN103100040A Traditional Chinese medicine pill for treating hysteria |
05/15/2013 | CN103100039A Traditional Chinese medicine pill for treating yin-deficiency and fire-hyperactivity type insomnia |
05/15/2013 | CN103100028A Soft capsule favorable for reducing alcoholic liver injury and preparation method thereof |
05/15/2013 | CN103100019A Body-building, brain-strengthening and kidney-nourishing agent |
05/15/2013 | CN103100017A Traditional Chinese medicine health care product for relieving muscle and bone pain and arthralgia and preparation method thereof |
05/15/2013 | CN103100011A Traditional Chinese medicinal composition and traditional Chinese medicinal preparation for treating gynecological diseases |
05/15/2013 | CN103100004A Pure traditional Chinese medicine preparation infantile malnutrition pills |